India's Drug Regulator Waits for UK Move Before Nod to SII's COVID Vax

Drug regulatory body of India is looking at the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval to AstraZeneca/Oxford's COVID-19 vaccine before approving Emergency Use Authorisation (EUA) to its Indian counterpart developed by Serum Institute of India (SII).

from Medindia Health News https://ift.tt/3aP3tgV